Select Page

EPICO considers establishing a company with an issued capital of EGP one billion

The board of directors of Egyptian International Pharmaceutical Industries Company (EIPICO), Egypt, has approved the initial feasibility study on proceeding with the legal procedures to establish an Egyptian joint-stock company.

That’s to manufacture pharmaceutical raw materials in the Suez Canal Economic Zone (SCzone).

The company stated that the issued capital will be about EGP one billion.

The paid-in capital is estimated at EGP 400 million, with EPICO’s share of 25%.